1. Home
  2. XBIT vs XPL Comparison

XBIT vs XPL Comparison

Compare XBIT & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.35

Market Cap

69.8M

Sector

Health Care

ML Signal

HOLD

Logo Solitario Resources Corp.

XPL

Solitario Resources Corp.

HOLD

Current Price

$0.80

Market Cap

68.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
XPL
Founded
2005
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
69.8M
68.1M
IPO Year
2015
2000

Fundamental Metrics

Financial Performance
Metric
XBIT
XPL
Price
$2.35
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.20
AVG Volume (30 Days)
32.8K
74.4K
Earning Date
05-08-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.86
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$0.54
52 Week High
$3.61
$0.98

Technical Indicators

Market Signals
Indicator
XBIT
XPL
Relative Strength Index (RSI) 54.27 60.64
Support Level $2.27 $0.70
Resistance Level $2.45 $0.82
Average True Range (ATR) 0.06 0.03
MACD 0.01 0.01
Stochastic Oscillator 48.00 99.17

Price Performance

Historical Comparison
XBIT
XPL

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About XPL Solitario Resources Corp.

Solitario Resources Corp is an exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. Its core mineral property assets are: the Florida Canyon zinc project in Peru, the Lik zinc project in Alaska, and the Golden Crest project in South Dakota. Additionally, Solitario holds an interest in the Chambara project in Peru and also has two early-stage projects, the Cat Creek project and the Bright Angel project in Colorado. The company is conducting mineral exploration on its Golden Crest project, the Cat Creek project, and the Bright Angel project on its own.

Share on Social Networks: